BIMINI Biotech has been awarded the NWO Take-off Phase 1 grant (€40.000) in collaboration with the Universitair Medisch Centrum Utrecht (UMCU) to perform an extensive feasibility study for BIMINI’s lead compound. The aim of the grant is to stimulate entrepreneurship and valorisation of breakthrough innovations that originate from Dutch Universities. This grant will help BIMINI…
Lees meer
BIMINI Biotech is the proud winner of the LSW Venture Challenge. Over the course of three months, we have been working hard on the business case of our breakthrough innovation – a novel cure for triple negative breast cancer. Now, we aim to accelerate the development of our lead compound to bring it to the…
Lees meer
On November 28th, 2019 BIMINI will be present at the 15th edition of the Dutch Life Sciences conference that takes place at the Leiden Bio Science Park, CORPUS Congress Centre. BIMINI will participate in the investor forum pitch sessions and we will pitch our breakthrough idea in 1 minute during the award sessions of the venture challenge. We…
Lees meer
November 2019 – BIMINI Biotech is participating in the LifeSciences@Work Accelerator Venture challenge. The Venture Challenge is a 10-week programme to develop an initial idea – a breakthrough research result – into a solid business case. We are happy to take on this challenge and define the optimal route to success for our company.
